We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
1451
DELISTED
Tivo Inc
TIVO
| $3.62M | 0.01% |
426,515
+24,550
| +6% | +$194K |
|
|
GES
1452
DELISTED
Guess Inc
GES
| $3.62M | 0.01% |
161,557
+4,277
| +3% | +$79.7K |
|
1453
Lazard
LAZ
$4.26B
| $3.62M | 0.01% |
90,477
+1,199
| +1% | +$45.3K |
|
|
GMS
1454
DELISTED
GMS Inc
GMS
| $3.61M | 0.01% |
133,469
+20,050
| +18% | +$588K |
|
|
QEP
1455
DELISTED
QEP RESOURCES, INC.
QEP
| $3.61M | 0.01% |
802,787
+24,824
| +3% | +$86.5K |
|
|
BECN
1456
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.6M | 0.01% |
112,582
+5,888
| +6% | +$186K |
|
1457
Resideo Technologies
REZI
$3.97B
| $3.6M | 0.01% |
301,642
+629
| +0.2% | +$7.16K |
|
|
ACIA
1458
DELISTED
Acacia Communications Inc
ACIA
| $3.6M | 0.01% |
53,067
+3,153
| +6% | +$209K |
|
1459
Ultragenyx Pharmaceutical
RARE
$2.46B
| $3.59M | 0.01% |
84,050
+3,419
| +4% | +$141K |
|
1460
Dropbox
DBX
$8.17B
| $3.58M | 0.01% |
199,790
+3,122
| +2% | +$58.8K |
|
1461
Nabors Industries
NBR
$1.16B
| $3.58M | 0.01% |
24,845
+1,411
| +6% | +$149K |
|
1462
Axsome Therapeutics
AXSM
$11B
| $3.57M | 0.01% |
34,576
+2,777
| +9% | +$112K |
|
|
NTUS
1463
DELISTED
Natus Medical Inc
NTUS
| $3.56M | 0.01% |
108,029
+5,622
| +5% | +$180K |
|
1464
PetMed Express
PETS
$42.1M
| $3.56M | 0.01% |
151,472
+2,407
| +2% | +$53.9K |
|
1465
CarGurus
CARG
$3.28B
| $3.56M | 0.01% |
101,173
+5,762
| +6% | +$204K |
|
1466
Photronics
PLAB
$1.89B
| $3.56M | 0.01% |
225,787
+10,793
| +5% | +$136K |
|
1467
Liberty Latin America Class C
LILAK
$1.66B
| $3.55M | 0.01% |
213,326
+4,198
| +2% | +$65K |
|
1468
National Healthcare
NHC
$3.46B
| $3.55M | 0.01% |
41,073
+335
| +0.8% | +$28K |
|
|
ARR
1469
Armour Residential REIT
ARR
$2.35B
| $3.55M | 0.01% |
39,682
+1,874
| +5% | +$160K |
|
|
TRTN
1470
DELISTED
Triton International Limited
TRTN
| $3.54M | 0.01% |
88,164
+187
| +0.2% | +$6.92K |
|
1471
Frontdoor
FTDR
$5.36B
| $3.53M | 0.01% |
74,534
+54
| +0.1% | +$2.53K |
|
1472
National Bank Holdings
NBHC
$1.93B
| $3.53M | 0.01% |
100,266
+6,396
| +7% | +$225K |
|
1473
Liberty Broadband Class A
LBRDA
$5.17B
| $3.51M | 0.01% |
28,204
+50
| +0.2% | +$5.79K |
|
1474
Lindsay Corp
LNN
$1.17B
| $3.51M | 0.01% |
36,553
+2,103
| +6% | +$192K |
|
1475
Stewart Information Services
STC
$2.07B
| $3.5M | 0.01% |
85,861
+5,221
| +6% | +$214K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.